Antheia is a startup based in the United States, most recent round Series-c-plus, 3 tracked investors.
Antheia is a startup based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Antheia uses synthetic biology to produce complex pharmaceutical ingredients through engineered yeast, transforming supply chains for essential medicines.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.